Optiver Holding B.V. acquired a new position in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 76 shares of the medical equipment provider’s stock, valued at approximately $27,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. AdvisorNet Financial Inc lifted its holdings in Align Technology by 140.0% during the 2nd quarter. AdvisorNet Financial Inc now owns 72 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the last quarter. Manchester Capital Management LLC bought a new position in shares of Align Technology in the first quarter valued at about $26,000. KB Financial Partners LLC acquired a new stake in shares of Align Technology during the 1st quarter worth about $26,000. Hanseatic Management Services Inc. bought a new stake in shares of Align Technology during the 2nd quarter worth about $36,000. Finally, First Manhattan CO. LLC. grew its stake in Align Technology by 593.8% in the 1st quarter. First Manhattan CO. LLC. now owns 111 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 95 shares during the last quarter. Institutional investors own 87.07% of the company’s stock.
Insider Buying and Selling
In other Align Technology news, CEO Joseph M. Hogan bought 5,194 shares of the stock in a transaction on Thursday, November 9th. The stock was purchased at an average price of $192.50 per share, with a total value of $999,845.00. Following the completion of the purchase, the chief executive officer now owns 208,664 shares in the company, valued at $40,167,820. The purchase was disclosed in a filing with the SEC, which is accessible through this link. In other Align Technology news, CEO Joseph M. Hogan bought 5,319 shares of the stock in a transaction on Tuesday, October 31st. The stock was purchased at an average price of $188.00 per share, with a total value of $999,972.00. Following the completion of the purchase, the chief executive officer now owns 203,470 shares in the company, valued at $38,252,360. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Joseph M. Hogan bought 5,194 shares of the stock in a transaction on Thursday, November 9th. The shares were acquired at an average cost of $192.50 per share, with a total value of $999,845.00. Following the purchase, the chief executive officer now owns 208,664 shares of the company’s stock, valued at approximately $40,167,820. The disclosure for this purchase can be found here. 0.64% of the stock is owned by corporate insiders.
Align Technology Trading Up 0.1 %
Align Technology (NASDAQ:ALGN – Get Free Report) last announced its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.62 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.86 by ($0.24). Align Technology had a net margin of 9.53% and a return on equity of 12.66%. The firm had revenue of $960.21 million during the quarter, compared to the consensus estimate of $994.60 million. On average, research analysts predict that Align Technology, Inc. will post 6.86 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
ALGN has been the subject of a number of research analyst reports. StockNews.com started coverage on Align Technology in a report on Thursday, October 5th. They set a “buy” rating for the company. Evercore ISI decreased their price objective on Align Technology from $400.00 to $320.00 in a report on Wednesday, October 11th. OTR Global raised Align Technology from a “mixed” rating to a “positive” rating in a report on Thursday, September 14th. HSBC assumed coverage on shares of Align Technology in a research note on Wednesday, August 30th. They issued a “buy” rating and a $450.00 price target on the stock. Finally, Jefferies Financial Group lifted their price objective on shares of Align Technology from $367.00 to $400.00 in a research note on Thursday, July 27th. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, Align Technology currently has a consensus rating of “Moderate Buy” and a consensus target price of $336.60.
Align Technology Profile
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services).
- Five stocks we like better than Align Technology
- What is an Earnings Surprise?
- The only two airline stocks worth buying: One is a Goldman pick
- Investing in Blue-Chip Stocks
- Ride the momentum: Apparel stocks soaring at 52-week highs
- Investing in the High PE Growth Stocks
- Safeguard your portfolio with these three bargain stocks
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.